Key statistics
On Thursday, Arrowhead Pharmaceuticals Inc (A2RR34:SAO) closed at 11.40, 57.46% above the 52 week low of 7.24 set on Apr 07, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 11.40 |
---|---|
High | 11.40 |
Low | 11.40 |
Bid | 10.20 |
Offer | 12.71 |
Previous close | 11.40 |
Average volume | 1.00 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Jul 03 2025 20:54 BST.
More ▼
Press releases
- Arrowhead Pharmaceuticals Initiates Phase 3 YOSEMITE Study of Investigational Zodasiran for the Treatment of Homozygous Familial Hypercholesterolemia
- Arrowhead Pharmaceuticals Completes Enrollment in SHASTA-3, SHASTA-4, and MUIR-3 Phase 3 Studies of Plozasiran
- Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-ALK7 for the Treatment of Obesity
- Arrowhead Pharmaceuticals to Participate in June 2025 Investor Conferences
- Arrowhead Pharmaceuticals Reports Fiscal 2025 Second Quarter Results
- Arrowhead Pharmaceuticals to Participate in May 2025 Investor Conferences
- Arrowhead Pharmaceuticals to Webcast Fiscal 2025 Second Quarter Results
- Arrowhead Pharmaceuticals Appoints Daniel Apel as Chief Financial Officer
More ▼